The Great Debate: To Treat or Not to Treat Pre RA

RT @RichardPAConway: Joerns et al. Baseline IL-17 higher in RD-ILD vs IPF. Low IL-13 assoc shorter progression free surv

Tweet Author

Tweet Content

Joerns et al. Baseline IL-17 higher in RD-ILD vs IPF. Low IL-13 assoc shorter progression free survival HR 17.36 @RheumNow #ACR22 Abstr#1109 https://t.co/I8R3SrxNfV https://t.co/he1A3SYDp0

Links

High Interleukin-13 Level Is Associated with Disease Stability in Interstitial … https://acrabstracts.org/abstract/high-interleukin-13-level-is-associated-with-…

RT @RichardPAConway: Goldman et al. RTX, TCZ in SSc ILD. 129 patients, 87 RTX, 32 TCZ, 10 both. Median changes in %FVC a

Tweet Author

RichardPAConway

Tweet Content

Goldman et al. RTX, TCZ in SSc ILD. 129 patients, 87 RTX, 32 TCZ, 10 both. Median changes in %FVC and %DLCO pre-and post-treatment were +0.35% and -0.8% for rituximab and -0.9% and +0.2% for tocilizumab. Majority stable/improved @RheumNow #ACR22 Abstr#1520 https://t.co/ydY5FGEYnQ https://t.co/O9QD7nkjdZ

Links

Rituximab and Tocilizumab and Their Effect on Lung Disease Progression in Scler… https://acrabstracts.org/abstract/rituximab-and-tocilizumab-and-their-effect-on…

RT @uptoTate: "Tweeting a conference is hard work!" @rheum_cat is right! Shout out to all of the #rheumtwitter, RN repo

Tweet Author

uptoTate

Tweet Content

"Tweeting a conference is hard work!" @rheum_cat is right! Shout out to all of the #rheumtwitter, RN reporters, conference attendees and all of those tweeting from home! #ACR22 @RheumNow

RT @RichardPAConway: Avouac @AvouacJerome et al. Maintaining complete B cell depletion assoc RTX efficacy in CTD-ILD. %

Tweet Author

RichardPAConway

Tweet Content

Avouac @AvouacJerome et al. Maintaining complete B cell depletion assoc RTX efficacy in CTD-ILD. % with FVC improvement - 67% vs 50% for B cell depletion 1 year, 89% vs 50% B cell depletion last infusion. @RheumNow #ACR22 Abstr#1527 https://t.co/xr7DHOHci2 https://t.co/2n95PgzLxN

Links

Maintained Complete B Cell Depletion Is Associated with Rituximab Efficacy in C… https://acrabstracts.org/abstract/maintained-complete-b-cell-depletion-is-assoc…

RT @RichardPAConway: Reid et al. Emphysema, lymphadenopathy, consolidative opacities on CT pre-ICI increase risk of ICI

Tweet Author

RichardPAConway

Tweet Content

Reid et al. Emphysema, lymphadenopathy, consolidative opacities on CT pre-ICI increase risk of ICI pneumonitis. Pul nodules decrease risk. GERD, asthma in history also increase risk. @RheumNow #ACR22 Abstr#1108 https://t.co/ZD8ibsECnV https://t.co/FVnQgn2I2S

Links

Abnormal Baseline Chest CT Shows Increased Risk for Immune Checkpoint Inhibitor… https://acrabstracts.org/abstract/abnormal-baseline-chest-ct-shows-increased-ri…

PsA and SPA: Cyclers, Switchers, Who is the Winner?

Day 1 Report The masses have returned to #ACR22, a hybrid meeting that began Saturday in Philadelphia. Throngs and ga

Tweet Author

RheumNow

Tweet Content

Day 1 Report The masses have returned to #ACR22, a hybrid meeting that began Saturday in Philadelphia. Throngs and gaggles of MSK wannabees crammed the ballrooms and rushed the exhibits as they relived the rheumatologic meeting we once knew. https://t.co/8GjRAT7Zuy https://t.co/vyXRcVxOpo

Links

https://bit.ly/3Es8fiF

Fertility issues in SpA

RT @synovialjoints: In RA after first-line TNFi, improvements in disease activity & PROs were seen with 2nd line ETN

Tweet Author

synovialjoints

Tweet Content

In RA after first-line TNFi, improvements in disease activity & PROs were seen with 2nd line ETN and JAKi. Some measures had greater improvement in JAKi group. Some patients can benefit from TNF cycling. Pappas D CorEvitas Abs1588 https://t.co/cHW5tm97kx #ACR22 @RheumNow https://t.co/bx0p04AQzd

Links

Outcomes of Etanercept and Janus Kinase Inhibitor Treatment After First-line Us… http://bit.ly/3hChW5h

Topics

The Great Debate: To Treat or Not to Treat Pre RA

RT @RichardPAConway: Joerns et al. Baseline IL-17 higher in RD-ILD vs IPF. Low IL-13 assoc shorter progression free surv

RT @RichardPAConway: Goldman et al. RTX, TCZ in SSc ILD. 129 patients, 87 RTX, 32 TCZ, 10 both. Median changes in %FVC a

RT @uptoTate: "Tweeting a conference is hard work!" @rheum_cat is right! Shout out to all of the #rheumtwitter, RN repo

RT @RichardPAConway: Avouac @AvouacJerome et al. Maintaining complete B cell depletion assoc RTX efficacy in CTD-ILD. %

RT @RichardPAConway: Reid et al. Emphysema, lymphadenopathy, consolidative opacities on CT pre-ICI increase risk of ICI

PsA and SPA: Cyclers, Switchers, Who is the Winner?

Day 1 Report The masses have returned to #ACR22, a hybrid meeting that began Saturday in Philadelphia. Throngs and ga

Fertility issues in SpA

RT @synovialjoints: In RA after first-line TNFi, improvements in disease activity & PROs were seen with 2nd line ETN

Do you get our email newsletter?

The Great Debate: To Treat or Not to Treat Pre RA

RT @RichardPAConway: Joerns et al. Baseline IL-17 higher in RD-ILD vs IPF. Low IL-13 assoc shorter progression free surv

RT @RichardPAConway: Goldman et al. RTX, TCZ in SSc ILD. 129 patients, 87 RTX, 32 TCZ, 10 both. Median changes in %FVC a

RT @uptoTate: "Tweeting a conference is hard work!" @rheum_cat is right! Shout out to all of the #rheumtwitter, RN repo

RT @RichardPAConway: Avouac @AvouacJerome et al. Maintaining complete B cell depletion assoc RTX efficacy in CTD-ILD. %

RT @RichardPAConway: Reid et al. Emphysema, lymphadenopathy, consolidative opacities on CT pre-ICI increase risk of ICI

PsA and SPA: Cyclers, Switchers, Who is the Winner?

Day 1 Report The masses have returned to #ACR22, a hybrid meeting that began Saturday in Philadelphia. Throngs and ga

Fertility issues in SpA

RT @synovialjoints: In RA after first-line TNFi, improvements in disease activity &amp; PROs were seen with 2nd line ETN

RT @synovialjoints: In RA after first-line TNFi, improvements in disease activity & PROs were seen with 2nd line ETN